About Custodix
Custodix is a Healthcare company based in Sint-martens-latem (Belgium) founded in 2000, and was acquired by TriNetX in April 2019. Clinical trial patient recruitment solutions are provided by Custodix. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is CUSTODIX NV.
Company details
Custodix was founded in 2000 as a provider of solutions for patient recruitment in clinical trials. Services are offered through the Insight Network product, encompassing clinical trial design, patient feasibility assessments, and workflow support for recruitment processes. Trusted third-party data collection is facilitated, alongside consultancy on data privacy. Clinical research is accelerated using real-world data in the healthcare sector.
- Headquarters Sint-martens-latem, Belgium
- Stage Acquired
- SectorsHealthcare
- Website custodix.com
- Acquired by TriNetX (Apr 2019)
- Legal Name Custodix Nv
Funding Insights of Custodix
- Total Rounds 1
- Last Round Grant — $362,205
- First Round $362,205
(Jan 2015)
- Investors Count 1
All 1 funding rounds of Custodix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2015 | $362,205 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Custodix
Custodix has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include TriNetX and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Clinical trial management software is provided for researchers and professionals. | 2013 | trinetx.com | Cambridge, United States |
Investor details for Custodix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Custodix
3 dated milestones of Custodix across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Custodix is founded.
- Funding First funding round of $362K.
- Exit Acquired by TriNetX.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Custodix
Custodix was founded in 2000 and raised its 1st funding round 15 years after it was founded.
Custodix is headquartered in Sint-martens-latem, Belgium. It is registered at Sint-martens-latem, East Flanders, Belgium.
Custodix was founded in 2000 as a provider of solutions for patient recruitment in clinical trials. Services are offered through the Insight Network product, encompassing clinical trial design, patient feasibility assessments, and workflow support for recruitment processes. Trusted third-party data collection is facilitated, alongside consultancy on data privacy. Clinical research is accelerated using real-world data in the healthcare sector.
Custodix has 2 investors. Key investors include TriNetX, and European Union.
Custodix operates through Custodix Nv.
Yes. Custodix was acquired by TriNetX in April 2019.